Intervention Effect of Transcranial Alternating Current Stimulation(tACS) on Anxiety Disorder

Launched by ANHUI MEDICAL UNIVERSITY · Aug 31, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called transcranial alternating current stimulation (tACS) to see how it can help reduce anxiety symptoms in people diagnosed with anxiety disorders. The researchers want to understand not only how effective this treatment is but also how it affects the brain, using a type of scan called MRI. The trial is currently looking for participants aged 18 to 60 who have been diagnosed with anxiety by at least two psychiatrists and meet certain criteria based on standardized assessments.

To join the study, participants need to be in good overall health and not have severe medical or neurological conditions. They should also be able to cooperate with the tests involved. Those who take part can expect to receive the tACS treatment and will be monitored to see how it impacts their anxiety and related symptoms. It’s important to know that individuals with certain medical devices or other mental health disorders may not be eligible for this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for anxiety, and HAMA\>14, PHQ-15\>5.
• • the age ranged from 18 to 60 years old, and the length of education was more than 5 years.
• • the visual acuity or corrected visual acuity is normal, right-handed, can cooperate with the completion of various experimental tests.
• Exclusion Criteria:
• • accompanied by severe somatic diseases, such as severe heart, liver, renal insufficiency and so on.
• • accompanied by other neurological diseases, such as stroke, epilepsy and so on. pregnant and lactating women. accompanied by other mental disorders, such as drug abuse, schizophrenia, schizophrenic affective disorder, hysteria, autism and so on.
• • patients with MRI taboos or factors affecting imaging quality, such as cardiac pacemaker, cochlear implant, cardio-cerebrovascular metal stent, metal denture, etc.
• • those who could not cooperate with those who completed the relevant experiments, such as patients with depressive stupor, claustrophobia and so on.